Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Flaxseed powder is a finely ground form of the seeds from the plant Linum usitatissimum. It is rich in alpha-linolenic acid (ALA), an omega-3 fatty acid, as well as lignans (phytoestrogens with antioxidant properties) and both soluble and insoluble fiber. Flaxseed powder is primarily used as a dietary supplement to support cardiovascular health by lowering cholesterol and blood pressure, improving glycemic control in diabetes, aiding digestive health through its laxative effects, supporting weight management by increasing satiety, and potentially reducing cancer risk due to its lignan content. The mechanisms of action are largely attributed to its high fiber content (which slows glucose absorption and reduces cholesterol uptake), ALA's anti-inflammatory effects on vascular tissue, and phytoestrogenic activity from lignans that may modulate hormone-related cancer risks[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on flaxseed powder.